The development of 11C-carbonylation chemistry: A systematic view
The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was...
Ausführliche Beschreibung
Autor*in: |
Eriksson, Jonas [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021transfer abstract |
---|
Umfang: |
23 |
---|
Übergeordnetes Werk: |
Enthalten in: Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time - Michaud, Jason E. ELSEVIER, 2023, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:92 ; year:2021 ; pages:115-137 ; extent:23 |
Links: |
---|
DOI / URN: |
10.1016/j.nucmedbio.2020.02.005 |
---|
Katalog-ID: |
ELV053001605 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV053001605 | ||
003 | DE-627 | ||
005 | 20230626034042.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210910s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nucmedbio.2020.02.005 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica |
035 | |a (DE-627)ELV053001605 | ||
035 | |a (ELSEVIER)S0969-8051(20)30038-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.88 |2 bkl | ||
100 | 1 | |a Eriksson, Jonas |e verfasserin |4 aut | |
245 | 1 | 4 | |a The development of 11C-carbonylation chemistry: A systematic view |
264 | 1 | |c 2021transfer abstract | |
300 | |a 23 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. | ||
520 | |a The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. | ||
700 | 1 | |a Antoni, Gunnar |4 oth | |
700 | 1 | |a Långström, Bengt |4 oth | |
700 | 1 | |a Itsenko, Oleksiy |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Michaud, Jason E. ELSEVIER |t Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |d 2023 |g Amsterdam [u.a.] |w (DE-627)ELV010596976 |
773 | 1 | 8 | |g volume:92 |g year:2021 |g pages:115-137 |g extent:23 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.nucmedbio.2020.02.005 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.88 |j Urologie |j Nephrologie |q VZ |
951 | |a AR | ||
952 | |d 92 |j 2021 |h 115-137 |g 23 |
author_variant |
j e je |
---|---|
matchkey_str |
erikssonjonasantonigunnarlngstrmbengtits:2021----:hdvlpetf1croyainhmsra |
hierarchy_sort_str |
2021transfer abstract |
bklnumber |
44.88 |
publishDate |
2021 |
allfields |
10.1016/j.nucmedbio.2020.02.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica (DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X DE-627 ger DE-627 rakwb eng 610 VZ 44.88 bkl Eriksson, Jonas verfasserin aut The development of 11C-carbonylation chemistry: A systematic view 2021transfer abstract 23 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. Antoni, Gunnar oth Långström, Bengt oth Itsenko, Oleksiy oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:92 year:2021 pages:115-137 extent:23 https://doi.org/10.1016/j.nucmedbio.2020.02.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 92 2021 115-137 23 |
spelling |
10.1016/j.nucmedbio.2020.02.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica (DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X DE-627 ger DE-627 rakwb eng 610 VZ 44.88 bkl Eriksson, Jonas verfasserin aut The development of 11C-carbonylation chemistry: A systematic view 2021transfer abstract 23 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. Antoni, Gunnar oth Långström, Bengt oth Itsenko, Oleksiy oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:92 year:2021 pages:115-137 extent:23 https://doi.org/10.1016/j.nucmedbio.2020.02.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 92 2021 115-137 23 |
allfields_unstemmed |
10.1016/j.nucmedbio.2020.02.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica (DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X DE-627 ger DE-627 rakwb eng 610 VZ 44.88 bkl Eriksson, Jonas verfasserin aut The development of 11C-carbonylation chemistry: A systematic view 2021transfer abstract 23 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. Antoni, Gunnar oth Långström, Bengt oth Itsenko, Oleksiy oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:92 year:2021 pages:115-137 extent:23 https://doi.org/10.1016/j.nucmedbio.2020.02.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 92 2021 115-137 23 |
allfieldsGer |
10.1016/j.nucmedbio.2020.02.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica (DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X DE-627 ger DE-627 rakwb eng 610 VZ 44.88 bkl Eriksson, Jonas verfasserin aut The development of 11C-carbonylation chemistry: A systematic view 2021transfer abstract 23 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. Antoni, Gunnar oth Långström, Bengt oth Itsenko, Oleksiy oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:92 year:2021 pages:115-137 extent:23 https://doi.org/10.1016/j.nucmedbio.2020.02.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 92 2021 115-137 23 |
allfieldsSound |
10.1016/j.nucmedbio.2020.02.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica (DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X DE-627 ger DE-627 rakwb eng 610 VZ 44.88 bkl Eriksson, Jonas verfasserin aut The development of 11C-carbonylation chemistry: A systematic view 2021transfer abstract 23 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. Antoni, Gunnar oth Långström, Bengt oth Itsenko, Oleksiy oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:92 year:2021 pages:115-137 extent:23 https://doi.org/10.1016/j.nucmedbio.2020.02.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 92 2021 115-137 23 |
language |
English |
source |
Enthalten in Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time Amsterdam [u.a.] volume:92 year:2021 pages:115-137 extent:23 |
sourceStr |
Enthalten in Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time Amsterdam [u.a.] volume:92 year:2021 pages:115-137 extent:23 |
format_phy_str_mv |
Article |
bklname |
Urologie Nephrologie |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
authorswithroles_txt_mv |
Eriksson, Jonas @@aut@@ Antoni, Gunnar @@oth@@ Långström, Bengt @@oth@@ Itsenko, Oleksiy @@oth@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
ELV010596976 |
dewey-sort |
3610 |
id |
ELV053001605 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053001605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626034042.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nucmedbio.2020.02.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053001605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-8051(20)30038-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.88</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eriksson, Jonas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The development of 11C-carbonylation chemistry: A systematic view</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">23</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoni, Gunnar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Långström, Bengt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Itsenko, Oleksiy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Michaud, Jason E. ELSEVIER</subfield><subfield code="t">Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time</subfield><subfield code="d">2023</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010596976</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:92</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:115-137</subfield><subfield code="g">extent:23</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nucmedbio.2020.02.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.88</subfield><subfield code="j">Urologie</subfield><subfield code="j">Nephrologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">92</subfield><subfield code="j">2021</subfield><subfield code="h">115-137</subfield><subfield code="g">23</subfield></datafield></record></collection>
|
author |
Eriksson, Jonas |
spellingShingle |
Eriksson, Jonas ddc 610 bkl 44.88 The development of 11C-carbonylation chemistry: A systematic view |
authorStr |
Eriksson, Jonas |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV010596976 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.88 bkl The development of 11C-carbonylation chemistry: A systematic view |
topic |
ddc 610 bkl 44.88 |
topic_unstemmed |
ddc 610 bkl 44.88 |
topic_browse |
ddc 610 bkl 44.88 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
g a ga b l bl o i oi |
hierarchy_parent_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
hierarchy_parent_id |
ELV010596976 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV010596976 |
title |
The development of 11C-carbonylation chemistry: A systematic view |
ctrlnum |
(DE-627)ELV053001605 (ELSEVIER)S0969-8051(20)30038-X |
title_full |
The development of 11C-carbonylation chemistry: A systematic view |
author_sort |
Eriksson, Jonas |
journal |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
journalStr |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
zzz |
container_start_page |
115 |
author_browse |
Eriksson, Jonas |
container_volume |
92 |
physical |
23 |
class |
610 VZ 44.88 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Eriksson, Jonas |
doi_str_mv |
10.1016/j.nucmedbio.2020.02.005 |
dewey-full |
610 |
title_sort |
development of 11c-carbonylation chemistry: a systematic view |
title_auth |
The development of 11C-carbonylation chemistry: A systematic view |
abstract |
The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. |
abstractGer |
The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. |
abstract_unstemmed |
The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
The development of 11C-carbonylation chemistry: A systematic view |
url |
https://doi.org/10.1016/j.nucmedbio.2020.02.005 |
remote_bool |
true |
author2 |
Antoni, Gunnar Långström, Bengt Itsenko, Oleksiy |
author2Str |
Antoni, Gunnar Långström, Bengt Itsenko, Oleksiy |
ppnlink |
ELV010596976 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.nucmedbio.2020.02.005 |
up_date |
2024-07-06T17:44:08.542Z |
_version_ |
1803852551074873344 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053001605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626034042.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nucmedbio.2020.02.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001288.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053001605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-8051(20)30038-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.88</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eriksson, Jonas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The development of 11C-carbonylation chemistry: A systematic view</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">23</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoni, Gunnar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Långström, Bengt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Itsenko, Oleksiy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Michaud, Jason E. ELSEVIER</subfield><subfield code="t">Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time</subfield><subfield code="d">2023</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010596976</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:92</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:115-137</subfield><subfield code="g">extent:23</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nucmedbio.2020.02.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.88</subfield><subfield code="j">Urologie</subfield><subfield code="j">Nephrologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">92</subfield><subfield code="j">2021</subfield><subfield code="h">115-137</subfield><subfield code="g">23</subfield></datafield></record></collection>
|
score |
7.399768 |